We are a biomarker discover company based on a new approach to analysis of "real-time" genetics or gene expression data. Our platform has produced several pre-clinical biomarkers that appear to have greater sensitivity and specificity than what is currently present in the field of molecular diagnostics. Our premier marker is a salivary biomarker identified for detection of breast cancer. By expanding the age range of breast cancer screening and increasing the compliance rate, a saliva test based on this marker would revolutionize breast cancer screening and early detection of breast cancer.
We have secured funding for a 200 subject clinical trial to be performed in India based on a co-marketing agreement with a molecular diagnostics company. We will design and manage the trial. The results from this trial will be used to develop products and services in India, which will later be expanded into other markets in Europe and US.
We are seeking approximately $400K to fund the design and management of the trial, co-marketing of any resulting products and services in India, and preliminary development of similar products in European and US markets.